ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Saxagliptin API Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24K7224
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Saxagliptin API Market Insights Forecast to 2027
BUY CHAPTERS

Global Saxagliptin API Market Research Report 2025

Code: QYRE-Auto-24K7224
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
TAPI (Teva)
API Polpharma
Metrochem API
Tianjin Scipharmacn
Taizhou Canova Bio-technology
Minxiang Pharma
Huaman Xincaiiao Keji
Jinan Lead Pharm-Chemical
Hebei Kangtai Pharma

Saxagliptin API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Saxagliptin API Market

Saxagliptin API Market

The global market for Saxagliptin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Saxagliptin is a highly effective dipeptidase -4 inhibitor. By selectively inhibiting dpp-4, endogenous levels of glucagon-like peptide-1 and glucose-dependent insulin-releasing peptides can be increased to regulate blood glucose.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Saxagliptin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saxagliptin API.
The Saxagliptin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Saxagliptin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saxagliptin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Saxagliptin API Market Report

Report Metric Details
Report Name Saxagliptin API Market
CAGR 5%
by Type
  • Purity≥98%
  • Purity≥99%
by Application
  • Saxagliptin Tablets
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Tapi Teva, API Polpharma, Metrochem API, Tianjin Scipharmacn, Taizhou Canova Bio-technology, Minxiang Pharma, Huaman Xincaiiao Keji, Jinan Lead Pharm-Chemical, Hebei Kangtai Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Saxagliptin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Saxagliptin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Saxagliptin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Saxagliptin API Market report?

Ans: The main players in the Saxagliptin API Market are AstraZeneca, Tapi Teva, API Polpharma, Metrochem API, Tianjin Scipharmacn, Taizhou Canova Bio-technology, Minxiang Pharma, Huaman Xincaiiao Keji, Jinan Lead Pharm-Chemical, Hebei Kangtai Pharma

What are the Application segmentation covered in the Saxagliptin API Market report?

Ans: The Applications covered in the Saxagliptin API Market report are Saxagliptin Tablets, Other

What are the Type segmentation covered in the Saxagliptin API Market report?

Ans: The Types covered in the Saxagliptin API Market report are Purity≥98%, Purity≥99%

1 Saxagliptin API Market Overview
1.1 Product Definition
1.2 Saxagliptin API by Type
1.2.1 Global Saxagliptin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Saxagliptin API by Application
1.3.1 Global Saxagliptin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Saxagliptin Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Saxagliptin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Saxagliptin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Saxagliptin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Saxagliptin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Saxagliptin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Saxagliptin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Saxagliptin API, Industry Ranking, 2023 VS 2024
2.4 Global Saxagliptin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Saxagliptin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Saxagliptin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Saxagliptin API, Product Offered and Application
2.8 Global Key Manufacturers of Saxagliptin API, Date of Enter into This Industry
2.9 Saxagliptin API Market Competitive Situation and Trends
2.9.1 Saxagliptin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Saxagliptin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Saxagliptin API Production by Region
3.1 Global Saxagliptin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Saxagliptin API Production Value by Region (2020-2031)
3.2.1 Global Saxagliptin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Saxagliptin API by Region (2026-2031)
3.3 Global Saxagliptin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Saxagliptin API Production Volume by Region (2020-2031)
3.4.1 Global Saxagliptin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Saxagliptin API by Region (2026-2031)
3.5 Global Saxagliptin API Market Price Analysis by Region (2020-2025)
3.6 Global Saxagliptin API Production and Value, Year-over-Year Growth
3.6.1 North America Saxagliptin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Saxagliptin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Saxagliptin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Saxagliptin API Production Value Estimates and Forecasts (2020-2031)
4 Saxagliptin API Consumption by Region
4.1 Global Saxagliptin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Saxagliptin API Consumption by Region (2020-2031)
4.2.1 Global Saxagliptin API Consumption by Region (2020-2025)
4.2.2 Global Saxagliptin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Saxagliptin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Saxagliptin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Saxagliptin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Saxagliptin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Saxagliptin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Saxagliptin API Production by Type (2020-2031)
5.1.1 Global Saxagliptin API Production by Type (2020-2025)
5.1.2 Global Saxagliptin API Production by Type (2026-2031)
5.1.3 Global Saxagliptin API Production Market Share by Type (2020-2031)
5.2 Global Saxagliptin API Production Value by Type (2020-2031)
5.2.1 Global Saxagliptin API Production Value by Type (2020-2025)
5.2.2 Global Saxagliptin API Production Value by Type (2026-2031)
5.2.3 Global Saxagliptin API Production Value Market Share by Type (2020-2031)
5.3 Global Saxagliptin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Saxagliptin API Production by Application (2020-2031)
6.1.1 Global Saxagliptin API Production by Application (2020-2025)
6.1.2 Global Saxagliptin API Production by Application (2026-2031)
6.1.3 Global Saxagliptin API Production Market Share by Application (2020-2031)
6.2 Global Saxagliptin API Production Value by Application (2020-2031)
6.2.1 Global Saxagliptin API Production Value by Application (2020-2025)
6.2.2 Global Saxagliptin API Production Value by Application (2026-2031)
6.2.3 Global Saxagliptin API Production Value Market Share by Application (2020-2031)
6.3 Global Saxagliptin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 AstraZeneca
7.1.1 AstraZeneca Saxagliptin API Company Information
7.1.2 AstraZeneca Saxagliptin API Product Portfolio
7.1.3 AstraZeneca Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 AstraZeneca Main Business and Markets Served
7.1.5 AstraZeneca Recent Developments/Updates
7.2 Tapi Teva
7.2.1 Tapi Teva Saxagliptin API Company Information
7.2.2 Tapi Teva Saxagliptin API Product Portfolio
7.2.3 Tapi Teva Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Tapi Teva Main Business and Markets Served
7.2.5 Tapi Teva Recent Developments/Updates
7.3 API Polpharma
7.3.1 API Polpharma Saxagliptin API Company Information
7.3.2 API Polpharma Saxagliptin API Product Portfolio
7.3.3 API Polpharma Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 API Polpharma Main Business and Markets Served
7.3.5 API Polpharma Recent Developments/Updates
7.4 Metrochem API
7.4.1 Metrochem API Saxagliptin API Company Information
7.4.2 Metrochem API Saxagliptin API Product Portfolio
7.4.3 Metrochem API Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Metrochem API Main Business and Markets Served
7.4.5 Metrochem API Recent Developments/Updates
7.5 Tianjin Scipharmacn
7.5.1 Tianjin Scipharmacn Saxagliptin API Company Information
7.5.2 Tianjin Scipharmacn Saxagliptin API Product Portfolio
7.5.3 Tianjin Scipharmacn Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Tianjin Scipharmacn Main Business and Markets Served
7.5.5 Tianjin Scipharmacn Recent Developments/Updates
7.6 Taizhou Canova Bio-technology
7.6.1 Taizhou Canova Bio-technology Saxagliptin API Company Information
7.6.2 Taizhou Canova Bio-technology Saxagliptin API Product Portfolio
7.6.3 Taizhou Canova Bio-technology Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Taizhou Canova Bio-technology Main Business and Markets Served
7.6.5 Taizhou Canova Bio-technology Recent Developments/Updates
7.7 Minxiang Pharma
7.7.1 Minxiang Pharma Saxagliptin API Company Information
7.7.2 Minxiang Pharma Saxagliptin API Product Portfolio
7.7.3 Minxiang Pharma Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Minxiang Pharma Main Business and Markets Served
7.7.5 Minxiang Pharma Recent Developments/Updates
7.8 Huaman Xincaiiao Keji
7.8.1 Huaman Xincaiiao Keji Saxagliptin API Company Information
7.8.2 Huaman Xincaiiao Keji Saxagliptin API Product Portfolio
7.8.3 Huaman Xincaiiao Keji Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Huaman Xincaiiao Keji Main Business and Markets Served
7.8.5 Huaman Xincaiiao Keji Recent Developments/Updates
7.9 Jinan Lead Pharm-Chemical
7.9.1 Jinan Lead Pharm-Chemical Saxagliptin API Company Information
7.9.2 Jinan Lead Pharm-Chemical Saxagliptin API Product Portfolio
7.9.3 Jinan Lead Pharm-Chemical Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Jinan Lead Pharm-Chemical Main Business and Markets Served
7.9.5 Jinan Lead Pharm-Chemical Recent Developments/Updates
7.10 Hebei Kangtai Pharma
7.10.1 Hebei Kangtai Pharma Saxagliptin API Company Information
7.10.2 Hebei Kangtai Pharma Saxagliptin API Product Portfolio
7.10.3 Hebei Kangtai Pharma Saxagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hebei Kangtai Pharma Main Business and Markets Served
7.10.5 Hebei Kangtai Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Saxagliptin API Industry Chain Analysis
8.2 Saxagliptin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Saxagliptin API Production Mode & Process Analysis
8.4 Saxagliptin API Sales and Marketing
8.4.1 Saxagliptin API Sales Channels
8.4.2 Saxagliptin API Distributors
8.5 Saxagliptin API Customer Analysis
9 Saxagliptin API Market Dynamics
9.1 Saxagliptin API Industry Trends
9.2 Saxagliptin API Market Drivers
9.3 Saxagliptin API Market Challenges
9.4 Saxagliptin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
TAPI (Teva)
API Polpharma
Metrochem API
Tianjin Scipharmacn
Taizhou Canova Bio-technology
Minxiang Pharma
Huaman Xincaiiao Keji
Jinan Lead Pharm-Chemical
Hebei Kangtai Pharma
List of Tables
 Table 1. Global Saxagliptin API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Saxagliptin API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Saxagliptin API Production Capacity (MT) by Manufacturers in 2024
 Table 4. Global Saxagliptin API Production by Manufacturers (2020-2025) & (MT)
 Table 5. Global Saxagliptin API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Saxagliptin API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Saxagliptin API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Saxagliptin API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Saxagliptin API as of 2024)
 Table 10. Global Market Saxagliptin API Average Price by Manufacturers (USD/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Saxagliptin API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Saxagliptin API, Product Offered and Application
 Table 13. Global Key Manufacturers of Saxagliptin API, Date of Enter into This Industry
 Table 14. Global Saxagliptin API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Saxagliptin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Saxagliptin API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Saxagliptin API Production Value Market Share by Region (2020-2025)
 Table 19. Global Saxagliptin API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Saxagliptin API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Saxagliptin API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Table 22. Global Saxagliptin API Production (MT) by Region (2020-2025)
 Table 23. Global Saxagliptin API Production Market Share by Region (2020-2025)
 Table 24. Global Saxagliptin API Production (MT) Forecast by Region (2026-2031)
 Table 25. Global Saxagliptin API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Saxagliptin API Market Average Price (USD/Kg) by Region (2020-2025)
 Table 27. Global Saxagliptin API Market Average Price (USD/Kg) by Region (2026-2031)
 Table 28. Global Saxagliptin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 29. Global Saxagliptin API Consumption by Region (2020-2025) & (MT)
 Table 30. Global Saxagliptin API Consumption Market Share by Region (2020-2025)
 Table 31. Global Saxagliptin API Forecasted Consumption by Region (2026-2031) & (MT)
 Table 32. Global Saxagliptin API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 34. North America Saxagliptin API Consumption by Country (2020-2025) & (MT)
 Table 35. North America Saxagliptin API Consumption by Country (2026-2031) & (MT)
 Table 36. Europe Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 37. Europe Saxagliptin API Consumption by Country (2020-2025) & (MT)
 Table 38. Europe Saxagliptin API Consumption by Country (2026-2031) & (MT)
 Table 39. Asia Pacific Saxagliptin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 40. Asia Pacific Saxagliptin API Consumption by Region (2020-2025) & (MT)
 Table 41. Asia Pacific Saxagliptin API Consumption by Region (2026-2031) & (MT)
 Table 42. Latin America, Middle East & Africa Saxagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 43. Latin America, Middle East & Africa Saxagliptin API Consumption by Country (2020-2025) & (MT)
 Table 44. Latin America, Middle East & Africa Saxagliptin API Consumption by Country (2026-2031) & (MT)
 Table 45. Global Saxagliptin API Production (MT) by Type (2020-2025)
 Table 46. Global Saxagliptin API Production (MT) by Type (2026-2031)
 Table 47. Global Saxagliptin API Production Market Share by Type (2020-2025)
 Table 48. Global Saxagliptin API Production Market Share by Type (2026-2031)
 Table 49. Global Saxagliptin API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Saxagliptin API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Saxagliptin API Production Value Market Share by Type (2020-2025)
 Table 52. Global Saxagliptin API Production Value Market Share by Type (2026-2031)
 Table 53. Global Saxagliptin API Price (USD/Kg) by Type (2020-2025)
 Table 54. Global Saxagliptin API Price (USD/Kg) by Type (2026-2031)
 Table 55. Global Saxagliptin API Production (MT) by Application (2020-2025)
 Table 56. Global Saxagliptin API Production (MT) by Application (2026-2031)
 Table 57. Global Saxagliptin API Production Market Share by Application (2020-2025)
 Table 58. Global Saxagliptin API Production Market Share by Application (2026-2031)
 Table 59. Global Saxagliptin API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Saxagliptin API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Saxagliptin API Production Value Market Share by Application (2020-2025)
 Table 62. Global Saxagliptin API Production Value Market Share by Application (2026-2031)
 Table 63. Global Saxagliptin API Price (USD/Kg) by Application (2020-2025)
 Table 64. Global Saxagliptin API Price (USD/Kg) by Application (2026-2031)
 Table 65. AstraZeneca Saxagliptin API Company Information
 Table 66. AstraZeneca Saxagliptin API Specification and Application
 Table 67. AstraZeneca Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 68. AstraZeneca Main Business and Markets Served
 Table 69. AstraZeneca Recent Developments/Updates
 Table 70. Tapi Teva Saxagliptin API Company Information
 Table 71. Tapi Teva Saxagliptin API Specification and Application
 Table 72. Tapi Teva Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Tapi Teva Main Business and Markets Served
 Table 74. Tapi Teva Recent Developments/Updates
 Table 75. API Polpharma Saxagliptin API Company Information
 Table 76. API Polpharma Saxagliptin API Specification and Application
 Table 77. API Polpharma Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. API Polpharma Main Business and Markets Served
 Table 79. API Polpharma Recent Developments/Updates
 Table 80. Metrochem API Saxagliptin API Company Information
 Table 81. Metrochem API Saxagliptin API Specification and Application
 Table 82. Metrochem API Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Metrochem API Main Business and Markets Served
 Table 84. Metrochem API Recent Developments/Updates
 Table 85. Tianjin Scipharmacn Saxagliptin API Company Information
 Table 86. Tianjin Scipharmacn Saxagliptin API Specification and Application
 Table 87. Tianjin Scipharmacn Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Tianjin Scipharmacn Main Business and Markets Served
 Table 89. Tianjin Scipharmacn Recent Developments/Updates
 Table 90. Taizhou Canova Bio-technology Saxagliptin API Company Information
 Table 91. Taizhou Canova Bio-technology Saxagliptin API Specification and Application
 Table 92. Taizhou Canova Bio-technology Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Taizhou Canova Bio-technology Main Business and Markets Served
 Table 94. Taizhou Canova Bio-technology Recent Developments/Updates
 Table 95. Minxiang Pharma Saxagliptin API Company Information
 Table 96. Minxiang Pharma Saxagliptin API Specification and Application
 Table 97. Minxiang Pharma Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Minxiang Pharma Main Business and Markets Served
 Table 99. Minxiang Pharma Recent Developments/Updates
 Table 100. Huaman Xincaiiao Keji Saxagliptin API Company Information
 Table 101. Huaman Xincaiiao Keji Saxagliptin API Specification and Application
 Table 102. Huaman Xincaiiao Keji Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Huaman Xincaiiao Keji Main Business and Markets Served
 Table 104. Huaman Xincaiiao Keji Recent Developments/Updates
 Table 105. Jinan Lead Pharm-Chemical Saxagliptin API Company Information
 Table 106. Jinan Lead Pharm-Chemical Saxagliptin API Specification and Application
 Table 107. Jinan Lead Pharm-Chemical Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Jinan Lead Pharm-Chemical Main Business and Markets Served
 Table 109. Jinan Lead Pharm-Chemical Recent Developments/Updates
 Table 110. Hebei Kangtai Pharma Saxagliptin API Company Information
 Table 111. Hebei Kangtai Pharma Saxagliptin API Specification and Application
 Table 112. Hebei Kangtai Pharma Saxagliptin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Hebei Kangtai Pharma Main Business and Markets Served
 Table 114. Hebei Kangtai Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Saxagliptin API Distributors List
 Table 118. Saxagliptin API Customers List
 Table 119. Saxagliptin API Market Trends
 Table 120. Saxagliptin API Market Drivers
 Table 121. Saxagliptin API Market Challenges
 Table 122. Saxagliptin API Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Saxagliptin API
 Figure 2. Global Saxagliptin API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Saxagliptin API Market Share by Type: 2024 VS 2031
 Figure 4. Purity≥98% Product Picture
 Figure 5. Purity≥99% Product Picture
 Figure 6. Global Saxagliptin API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Saxagliptin API Market Share by Application: 2024 VS 2031
 Figure 8. Saxagliptin Tablets
 Figure 9. Other
 Figure 10. Global Saxagliptin API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Saxagliptin API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Saxagliptin API Production Capacity (MT) & (2020-2031)
 Figure 13. Global Saxagliptin API Production (MT) & (2020-2031)
 Figure 14. Global Saxagliptin API Average Price (USD/Kg) & (2020-2031)
 Figure 15. Saxagliptin API Report Years Considered
 Figure 16. Saxagliptin API Production Share by Manufacturers in 2024
 Figure 17. Global Saxagliptin API Production Value Share by Manufacturers (2024)
 Figure 18. Saxagliptin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Saxagliptin API Revenue in 2024
 Figure 20. Global Saxagliptin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Saxagliptin API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Saxagliptin API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 23. Global Saxagliptin API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Saxagliptin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Saxagliptin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Saxagliptin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Saxagliptin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Saxagliptin API Consumption by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 29. Global Saxagliptin API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 31. North America Saxagliptin API Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 33. Canada Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 34. Europe Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 35. Europe Saxagliptin API Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 37. France Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 38. U.K. Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 39. Italy Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 40. Russia Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 41. Asia Pacific Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 42. Asia Pacific Saxagliptin API Consumption Market Share by Region (2020-2031)
 Figure 43. China Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 44. Japan Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 45. South Korea Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 46. China Taiwan Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 47. Southeast Asia Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 48. India Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 49. Latin America, Middle East & Africa Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 50. Latin America, Middle East & Africa Saxagliptin API Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 52. Brazil Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 53. Turkey Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 54. GCC Countries Saxagliptin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 55. Global Production Market Share of Saxagliptin API by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Saxagliptin API by Type (2020-2031)
 Figure 57. Global Saxagliptin API Price (USD/Kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Saxagliptin API by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Saxagliptin API by Application (2020-2031)
 Figure 60. Global Saxagliptin API Price (USD/Kg) by Application (2020-2031)
 Figure 61. Saxagliptin API Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Saxagliptin Market Research Report 2025
Saxagliptin Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sitagliptin API Market Research Report 2025
Global Sitagliptin Phosphate API Market Research Report 2025
Global Peptide API Market Research Report 2024
Global DPP 4 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025
Global Sitagliptin Tablet Market Research Report 2025
Global PDE Inhibitors Market Research Report 2024
Global Pregabalin API Market Research Report 2025
Global Linagliptin API Market Research Report 2025
Global Sitagliptin Phosphate Tablets Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Gabapentin API Market Research Report 2024
DPP 4 Inhibitor Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Somatostatin API Market Research Report 2024
Global Oral Peptide Therapeutics Market Research Report 2024
Dipeptidyl Peptidase IV DPP IV Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ovalbumin Peptide Market Research Report 2024
Global Upadacitinib API Market Research Report 2024
Global Polypeptide API Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions